Order PD-L1 Tissue Assay

Aurora Diagnostics LMC Laboratories is one of the first laboratories to provide the FDA-approved VENTANA PD-L1 (SP142) Assay. The complementary assay is an immunohistochemical tissue assay corresponding with the release of TECENTRIQ™ (atezolizumab). This test is the first to evaluate patient PD-L1 status using immune cell staining and scoring within the tumor microenvironment, providing clinicians with information that may guide immunotherapy decisions.

To order the PD-L1 Tissue Assay call 877-LMC-LABS